Spain Gene Therapy Starting Materials Market Size & Outlook
Related Markets
Spain gene therapy starting materials market highlights
- The Spain gene therapy starting materials market generated a revenue of USD 33.8 million in 2024 and is expected to reach USD 77.1 million by 2030.
- The Spain market is expected to grow at a CAGR of 14.8% from 2025 to 2030.
- In terms of segment, viral vectors was the largest revenue generating product in 2024.
- Plasmid DNA is the most lucrative product segment registering the fastest growth during the forecast period.
Gene therapy starting materials market data book summary
| Market revenue in 2024 | USD 33.8 million |
| Market revenue in 2030 | USD 77.1 million |
| Growth rate | 14.8% (CAGR from 2025 to 2030) |
| Largest segment | Viral vectors |
| Fastest growing segment | Plasmid DNA |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Viral Vectors, Plasmid DNA, Cell Lines, Others Product |
| Key market players worldwide | Charles River Laboratories International Inc, Genscript Biotech Corp Class H, Thermo Fisher Scientific Inc, Lonza Group Ltd, Catalent Inc, Eurofins Scientific SE, Danaher Corp, Merck KGaA, Sartorius AG |
Other key industry trends
- In terms of revenue, Spain accounted for 1.8% of the global gene therapy starting materials market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany gene therapy starting materials market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 398.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Therapy Starting Materials Market Scope
Gene Therapy Starting Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Genscript Biotech Corp Class H | View profile | 6937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | https://www.genscript.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Sartorius AG | View profile | 14338 | Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 | https://www.sartorius.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Spain gene therapy starting materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene therapy starting materials market will help companies and investors design strategic landscapes.
Viral vectors was the largest segment with a revenue share of 49.7% in 2024. Horizon Databook has segmented the Spain gene therapy starting materials market based on viral vectors, plasmid dna, cell lines, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Spain gene therapy starting materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain gene therapy starting materials market databook
-
Our clientele includes a mix of gene therapy starting materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain gene therapy starting materials market , including forecasts for subscribers. This country databook contains high-level insights into Spain gene therapy starting materials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain gene therapy starting materials market size, by product, 2018-2030 (US$M)
Spain Gene Therapy Starting Materials Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
